Major Medical Groups Urge States to Use Juul Settlement for Anti-Smoking Programs

Sep.29.2022
Major Medical Groups Urge States to Use Juul Settlement for Anti-Smoking Programs
Health groups urge states to use $438.5 million Juul settlement for tobacco prevention programs, especially for youth.

Major medical organizations are urging the state, which won a $438.5 million settlement against e-cigarette manufacturer Juul Labs Inc. earlier this month, to use the money towards tobacco prevention and cessation programs, particularly for young people.


Selling electronic cigarette products to children is illegal in all 50 states. However, since Juul released its sweet-flavored electronic cigarettes in 2017, there has been an increase in teenage use of nicotine-containing products. States and school districts have launched various educational campaigns aimed at discouraging children from using harmful and addictive products.


On September 6th, a settlement agreement was reached that not only requires Juul to pay fees to each state over the course of 6-10 years, but also prohibits the company from conducting any further marketing campaigns targeting young people. The agreement also restricts the range of product sales and advertising, prohibits the use of unapproved flavors by the US Food and Drug Administration, and prohibits the marketing of free samples and branded goods.


In a letter dated September 27, the Campaign for Tobacco-Free Kids, the American Cancer Society Cancer Action Network, the American Heart Association, the American Lung Association, and Americans for Nonsmokers' Rights and Truth Initiative have called on states to "build on the historic 1998 Master Settlement Agreement (MSA) with the tobacco industry, while avoiding some of the mistakes that were made, to achieve further success.


These organizations cited a report from the Smoke-Free Kids campaign, which showed that only 2.7% of the $27 billion in tobacco settlements and taxes collected by states in the 2022 fiscal year were allocated towards programs aimed at preventing children from smoking and assisting smokers in quitting.


Connecticut Attorney General William Tong stated in his announcement of the proposed settlement, expected to be finalized in October, that JUUL's flippant advertising campaigns have created a new generation of nicotine addicts. "They shamelessly marketed their e-cigarette products to minors, manipulated their chemical makeup to make them palatable to inexperienced users, utilized inadequate age verification procedures, and misled consumers about the nicotine content and addictiveness of their products," Tong wrote.


In a statement, Juul has said that the settlement agreement is "an important component of our ongoing efforts to address past issues.


It further stated, "The terms of this agreement are consistent with our current business practices implemented company-wide after being reset in the fall of 2019.


According to data from the Centers for Disease Control and Prevention, over two million high school students reported using e-cigarettes in 2021, with eight out of ten students using flavored products.


In 2019, Governor Gretchen Whitmer made Michigan the first state to ban flavored e-cigarette products in an effort to reduce youth vaping. Other states have also issued similar orders, and all states have incorporated e-cigarettes into laws that restrict the sale of tobacco to minors. At least 18 states have raised the legal smoking age to 21.


In 2020, the FDA banned all nicotine products flavors except for menthol and tobacco.


During the announcement of the settlement agreement, several state attorneys general stated their intention to use the funds for smoking cessation and prevention programs. Health organizations urged all states in a letter to "translate this admirable intention into a strong commitment expressed in the final text of the agreement.


In 2020, the Attorneys General of Connecticut, Oregon, and Texas began investigating the company's marketing and sales practices, with 30 other states joining the effort: Alabama, Arkansas, Delaware, Georgia, Hawaii, Idaho, Indiana, Kansas, Kentucky, Maryland, Maine, Mississippi, Montana, North Dakota, Nebraska, New Hampshire, New Jersey, Nevada, Ohio, Oklahoma, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Virginia, Vermont, Wisconsin, and Wyoming.


Afterward, the state of Maine chose to withdraw from the settlement.


Statement:


This article is compiled from third-party information and is provided solely for industry professionals to exchange and learn from.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot verify the truth or accuracy of the article's content. The compilation of this article is only intended for industry-related exchange and research.


Due to limitations in our translation abilities, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.


In regards to any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions, 2FIRSTS maintains complete alignment with the Chinese government.


The ownership of the copyright for the compiled information belongs to the original media and authors. If there is any infringement, please contact us for the information to be deleted.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
At InterTabac 2026, nicotine pouch growth was visible not only in brands but across equipment, raw materials and OEM manufacturing. 2Firsts interviewed AIRSCREAM commercial head Steve Moore on how many pouch factories Europe may ultimately need and where manufacturers can differentiate, from formulation and flavour to pouch materials, production consistency and customer service. The category continues to expand, but questions remain over future capacity, consolidation and the long-term structure of the supply chain.
Sep.18
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia’s tobacco excise debate is increasingly exposing differences within the governing Labor Party. New South Wales Labor Premier Chris Minns reaffirmed on September 8 that he supports reducing tobacco excise, arguing that current tax settings are pushing consumers toward cheaper black-market cigarettes. Federal Health Minister Mark Butler continues to oppose an excise cut, while Treasurer Jim Chalmers and Assistant Treasurer Daniel Mulino have recently stopped short of ruling out future changes. The divergence follows the opposition Coalition’s proposal to cut tobacco excise by 80%.
Sep.08
How Large Is France’s Off-Channel Tobacco Market? Logista Says It Has Become Structural, While the Official Estimate Is 17.7% and Some Industry Studies Put It Above 50%
How Large Is France’s Off-Channel Tobacco Market? Logista Says It Has Become Structural, While the Official Estimate Is 17.7% and Some Industry Studies Put It Above 50%
Logista France says tobacco consumption outside France’s official tobacconist network has become a large and structural market phenomenon, but official and industry estimates differ sharply. France’s TAFE study estimates that 17.7% of tobacco consumption escaped domestic taxation in 2023, with most of that volume attributed to cross-border purchasing rather than street sales. Some industry studies use broader off-channel definitions and put the figure above 50%. Meanwhile, French Customs seized 547.94 tonnes of tobacco in 2025, up 12%, showing continued pressure from illicit trade.
Sep.04
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
The HQD SiSA 80K Hookah Disposable Vape has appeared across U.S. and cross-border online retail channels. The device comes prefilled with 28ml of e-liquid, uses a 5% nicotine salt configuration and carries a brand claim of up to 80,000 puffs. Beyond puff count, the product differentiates itself through hookah-inspired features including adjustable airflow, a flowing-water sound effect and flavor options associated with traditional hookah consumption.
Aug.18